The next wave of AI investment is creating new cost structures, value drivers and financial risks that traditional ROI models were never designed to measure
Chronic kidney disease affects more than 850 million people worldwide and continues to impose a heavy clinical and economic burden. Despite its scale, progress in kidney disease research and drug development lags behind other therapeutic areas.
Reclaiming a company’s independence after a period under new ownership demands strategic foresight, operational resilience, and a clear vision for the future
Forecasts shape major decisions, but are rarely scored with any seriousness; over time, companies accumulate decisions without accumulating forecasting memory
I have a diabolical idea and I’m inviting all of you to get in on it with me. Ever wanted to throw a metaphorical spanner into the equally metaphorical gears of your (or someone else’s) company?
The majority of enterprise knowledge remains trapped in documents, emails, PDFs, and other unstructured formats that AI cannot reliably interpret or act upon